Forventes på lager: 23-08-2016
Cancer patients have benefitted greatly from recent advances in the drugs, dose regimens, and combinations used to treat their primary tumor and for the treatment or prevention of spread of their disease. With the increase in survival rates, there has emerged a new awareness of these chronic adverse effects.
| Forlag | Springer-Verlag New York Inc. |
| Type | Bog |
| Format | Paperback / softback |
| Sprog | Engelsk |
| Udgave | Softcover reprint of the original 1st ed. 2010 |
| Udgivelsesdato | 23-08-2016 |
| Første udgivelsesår | 2016 |
| Serie | Advances in Experimental Medicine and Biology |
| Illustrationer | XXI, 216 p. |
| Fagredaktør | Robert B. Raffa, Ronald J. Tallarida |
| Originalsprog | United States |
| Sideantal | 216 |
| Indbinding | Paperback / softback |
| Forlag | Springer-Verlag New York Inc. |
| Sideoplysninger | 216 pages, XXI, 216 p. |
| Mål | 254 x 178 |
| ISBN-13 / EAN-13 | 9781493940998 |